The higher the blood sugar level in pregnant women when first diagnosed with diabetes, the higher the risk of complications around and after birth, according to research presented at the 26th European Congress of Endocrinology in Stockholm.
Another Eylea threat: Roche expands label for blockbuster eye drug Vabysmo
With hopes of dethroning Regeneron’s blockbuster eye drug franchise Eylea, Roche on Thursday announced the FDA has expanded the label of its own blockbuster eye
October 28, 2023